Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Page 1
| Issued: 10 March 2008 at 11:00 |
Ref: MDA/2008/013
|
|
|
Immediate action |
|
Action |
|
|
Update |
|
|
Information request |
| Device: Heel & Elbow and Heel & Ankle Gelbodies used to help prevent pressure ulcers. Manufactured by Trulife. |
>Page 2 |
||||||||||||
| Problem: Risk of broken skin, friction burns, and redness from using Heel & Elbow and Heel & Ankle Gelbodies over a period of prolonged continuous use. |
>Page 2 |
||||||||||||
| Action by: All those involved in the provision, prescription and use of Gelbodies. In particular nurses and care staff. |
|||||||||||||
|
Action:
|
|||||||||||||
|
Distributed to:
* via CE Bulletin |
>Page 2 |
||||||||||||
| Contacts: Details of manufacturer contacts and MHRA contacts for technical and clinical aspects. Change of address or removal from address list for CSCI and Healthcare Commission. |
>Pages 2-3 |
|
Action deadlines for the Safety Alert Broadcast System (SABS)
|
|
|
Deadline (action underway): 10 April 2008
|
Deadline (action complete): 10 June 2008
|

